Mindset Pharma Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its DMT and 5-MeO-DMT Inspired… Aug 24, 2021
Mindset Pharma Announces Publication of Three PCT Patent Applications for Its Next Generation Psychedelic Drug… Aug 16, 2021
atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions Aug 12, 2021
Awakn Life Sciences Begins Trading on the OTCQB(R) Venture Market Under the Symbol ‘AWKNF’ on August 12th Aug 12, 2021
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021 Aug 11, 2021
